Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success
STAT News · LC · trust 38/100
Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA vaccines to target tumors.
Read the original at STAT News →
Open in TruthVane →